Related Experiment Video
Updated: Jun 4, 2025
Technical Detail for Robot Assisted Pancreaticoduodenectomy
Published on: September 28, 2019
External Validation of the International Study Group for Pancreatic Surgery Complexity Grading System for Minimally
Niccolò Napoli1, Greta Donisi2,3, Emanuele F Kauffmann1
1Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.
Objective:
To validate the International Study Group for Pancreatic Surgery (ISGPS) complexity grading system for minimally invasive pancreaticoduodenectomy (MIPD).
Background:
Although concerns about patient safety persist, MIPD is gaining popularity. The ISGPS recently introduced a difficulty grading system to improve patient selection by aligning procedural complexity with surgeon and center expertise.
Methods:
Data from MIPD cases reported in the IGOMIPS registry (October 2019-February 2024) were analyzed, with severe postoperative complications as the primary outcome. Logistic regression was used to identify risk factors for complications.
Results:
Of the 771 MIPD cases, 426 (55.3%) were analyzed. A pancreatic duct size ≤3 mm was the only significant risk factor for severe complications (odds ratio = 2.22, P = 0.0001). Most cases (n = 255; 59.9%) were classified as grade C complexity, whereas 22 (5.1%) were classified as grade A. Severe postoperative complications increased with complexity (grade A, 31.8%; grade B, 36.3%; grade C, 48.6%; P = 0.0091). For grade A complexity, the outcomes were consistent across surgeons and centers. Grade B outcomes were similar between grade B and C centers but superior to grade A centers. In grade C cases, outcomes were comparable between grade A and B centers, with improvements at grade C centers. Grade A ISGPS experience correlated strongly with mismatches between planned and performed procedures (grade A, 15.0%; grade B, 3.0%; grade C, 3.1%; P < 0.0001), including total pancreatectomy (grade A, 11.5%; grade B, 1.2%; grade C, 3.1%; P = 0.0005).
Conclusions:
The ISGPS complexity grading system effectively predicted MIPD outcomes, supporting better patient selection and alignment of complexity with surgical expertise.
Insights
The International Study Group for Pancreatic Surgery (ISGPS) complexity grading system accurately predicts outcomes for minimally invasive pancreaticoduodenectomy (MIPD). This tool aids in matching surgical complexity with surgeon and center expertise for improved patient safety.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Minimally Invasive Surgery
Background:
- Minimally invasive pancreaticoduodenectomy (MIPD) is increasingly adopted despite patient safety concerns.
- The International Study Group for Pancreatic Surgery (ISGPS) developed a complexity grading system to guide patient selection based on procedural difficulty and expertise.
Purpose of the Study:
- To validate the efficacy of the ISGPS complexity grading system in predicting outcomes for minimally invasive pancreaticoduodenectomy (MIPD).
- To assess the relationship between ISGPS complexity grades, surgeon/center expertise, and postoperative complications.
Main Methods:
- Analysis of 426 MIPD cases from the IGOMIPS registry (October 2019-February 2024).
- Severe postoperative complications were the primary outcome measure.
- Logistic regression analysis identified risk factors for complications, including pancreatic duct size.
Main Results:
- A narrow pancreatic duct (≤3 mm) was the sole significant predictor of severe complications (OR=2.22).
- Severe complications increased with ISGPS complexity grade (A: 31.8%, B: 36.3%, C: 48.6%).
- Outcomes aligned with ISGPS complexity, with better results in centers matching complexity grade (e.g., grade C centers for grade C cases). Mismatches, particularly in grade A cases, led to more complex procedures like total pancreatectomy.
Conclusions:
- The ISGPS complexity grading system effectively predicts MIPD outcomes.
- The system supports improved patient selection by aligning procedural complexity with surgeon and center expertise.
- Validation of the ISGPS system enhances patient safety in minimally invasive pancreatic surgery.
